Background: The aim of the current case report is to re-evaluate the key features and pitfalls of fine-needle aspiration cytology (FNAC) in the diagnosis of sclerosing pneumocytoma (previously named sclerosing hemangioma) and to establish the importance of FNAC in addressing a proper surgical strategy. Case: Herein we documented a case of a 70- year-old man with a lung nodule which showed a hypermetabolic uptake on positron emission tomography. He therefore underwent FNAC under computed tomography scan guidance with a 22-gauge needle. The cytopathological examination allowed a diagnosis of sclerosing pneumocytoma. A wedge surgical excision was performed and the histological examination confirmed the cytological diagnosis. Conclusion: FNAC is a fundamental tool for distinguishing sclerosing pneumocytoma from a malignant lung tumour and together with clinical, radiological and pathological multidisciplinary assessment is indispensable in planning appropriate surgical management. Cytopathologists should be aware of the pitfalls and key features of the cytopathological diagnosis of sclerosing pneumocytoma, which can significantly change the surgical approach to the patient and protect him from aggressive overtreatment.

Keywords:
Lung adenocarcinoma, Fine-needle aspiration cytology, Sclerosing pneumocytoma
1.
Beasly MB, Travis WD: Sclerosing pneumocytoma; in Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG (eds): World Health Organization Classification of Tumours of the Lung, Pleura, Thymus and Heart. Lyon, IARC, 2015, pp 110-111.
2.
Liebow AA, Hubbell DS: Sclerosing hemangioma (histiocytoma, xanthoma) of the lung. Cancer 1956;9:53-75.
3.
Devouassoux-Shisheboran M, Hayashi T, Linnoila RI, Koss MN, Travis WD: A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium. Am J Surg Pathol 2000;24:906-916.
4.
Tanaka I, Inoue M, Matsui Y, Oritsu S, Akiyama O, Takemura T, Fujiwara M, Kodama T, Shimosato Y: A case of pneumocytoma (so-called sclerosing hemangioma) with lymph node metastasis. Jpn J Clin Oncol 1986;16:77-86.
5.
Keylock JB, Galvin JR, Franks TJ: Sclerosing hemangioma of the lung. Arch Pathol Lab Med 2009;133:820-825.
6.
Erozan YS, Ramzy I: Pneumocytoma in pulmonary cytopathology; in Essentials in Cytopathology. New York, Springer, 2009, pp 97-101.
7.
Ng WK, Fu KH, Wang E, Tang V: Sclerosing hemangioma of lung: a close cytologic mimicker of pulmonary adenocarcinoma. Diagn Cytopathol 2001;25:316-320.
8.
Gal AA, Nassar VH, Miller JI: Cytopathologic diagnosis of pulmonary sclerosing hemangioma. Diagn Cytopathol 2002;26:1063-1166.
9.
Dettrick A, Meikle A, Fong KM: Fine-needle aspiration diagnosis of sclerosing hemangioma (pneumocytoma): report of a case and review of the literature. Diagn Cytopathol 2012;42:242-246.
10.
Gupta M, Shah J, Manipadam MT, Rao VM: Case of pulmonary pneumocytoma: a probable cytological diagnosis with histopathological confirmation. Indian J Pathol Microbiol 2014;57:89-91.
11.
Islam S, Roustan Delatour NL, Salahdeen SR, Mai KT, Senterman M, Mokhtar GA: Cytologic features of benign solitary pulmonary nodules with radiologic correlation and diagnostic pitfalls: a report of six cases. Acta Cytol 2009;53:201-210.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.